NICOLE RIZZO: Open Payments
NPI 1649927922 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,642 in 159 payments from 17 companies in 2025. Trend: 2023 $944 · 2024 $2,507 · 2025 $2,642
Food & beverage: $2,642
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $654 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $383 |
| Janssen Biotech, Inc. | 18 | $351 |
| Madrigal Pharmaceuticals | 21 | $291 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $259 |
| GENZYME CORPORATION | 9 | $152 |
| Ardelyx, Inc. | 6 | $118 |
| Lilly USA, LLC | 7 | $118 |
| Amgen Inc. | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 6 | $56 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, XIFAXAN, ENTYVIO, DUPIXENT, IBSRELA, OMVOH.
Industry payments across NJ — which companies pay providers there.
